1e
19
1
49
2
2
18
1b
1d
18
36
56
1d
2 29
1d
25
Erle S. Robertson, Ph.D.
78
56
Harry P. Schenck Professor in Otorhinolaryngology
28
9e
3
81
Program Leader, Tumor Virology Training Program, University of Pennsylvania, Department of Microbiology
11
Department: Otorhinolaryngology: Head and Neck Surgery
4
1
23
1f
Graduate Group Affiliations
8
a
b
1d
46
Contact information
43
4
3
3
1d
43
201E Johnson Pavilion
35 3610 Hamilton Walk
Philadelphia, PA 19104
26
35 3610 Hamilton Walk
Philadelphia, PA 19104
2e
Office: 215-746-0114
32 Fax: 215-746-0115
32 Lab: 215-746-0116
18
97
32 Fax: 215-746-0115
32 Lab: 215-746-0116
18
Email:
erle@pennmedicine.upenn.edu
12
erle@pennmedicine.upenn.edu
18
Publications
23 a
3
2
29
23 a
Links
92 Search PubMed for articles
60 Robertson Lab
7f Department of Microbiology-University of Pennsylvania
8f Henle Symposium. Herpesvirus: PATHOGENESIS AND CANCER
47 Cell and Molecular Biology graduate group faculty webpage.
c
4
b
1f
92 Search PubMed for articles
60 Robertson Lab
7f Department of Microbiology-University of Pennsylvania
8f Henle Symposium. Herpesvirus: PATHOGENESIS AND CANCER
47 Cell and Molecular Biology graduate group faculty webpage.
c
13
Education:
21 a B.Sc. 19 (Microbiology) c
59 Howard University, Washington, DC, Dean's list for entire period, 1987.
21 8 PhD 30 (Microbiology and Molecular Genetics) c
28 Wayne State University, Detroit, MI 34 Mentor: Allan Nicholson, Ph.D., 1992.
21 7 MS 1d (Honorary Masters) c
33 University of Pennsylvania, 2003.
c
3
3
3
3
8b
Permanent link21 a B.Sc. 19 (Microbiology) c
59 Howard University, Washington, DC, Dean's list for entire period, 1987.
21 8 PhD 30 (Microbiology and Molecular Genetics) c
28 Wayne State University, Detroit, MI 34 Mentor: Allan Nicholson, Ph.D., 1992.
21 7 MS 1d (Honorary Masters) c
33 University of Pennsylvania, 2003.
c
2 29
21
1e
1d
24
5e
37 Mechanisms of Oncogenesis by Gammaherpesvirus.
8
cd Key words: oncogenesis, viruses and cancer, viral oncology, Tumor Virology, Gene therapy, Kaposi's Sarcoma, Epstein-Barr Virus, Lymphoproliferative disease, Lymphomas, Microbiome and Cancer.
8
26 Description of Research
287 Epstein-Barr virus (EBV) and Kaposi's sarcoma associated herpesvirus (KSHV) are associated with a number of human malignancies. These include Burkitt's lymphoma, nasopharyngeal carcinoma, Hodgkin's lymphoma, breast carcinoma, Kaposi's sarcoma and body cavity based lymphoma. We are investigating the fundamental mechanisms utilized by these gammaherpesviruses to induce cell mediated growth transformation. We are using genetics, genomics and biochemical approaches to establish unknown pathways involved in these cellular events and attempting to develop models that explain how gammaherpesviruses establish transformation in human cells.
8
3f7 EBV infects human B-lymphocytes and is the etiological agent of infectious mononucleosis. In vitro EBV efficiently growth transforms primary B-lymphocytes. Studies have demonstrated that only a subset of the viral latent genes is essential for EBV mediated transformation. One such gene is the EBV nuclear antigen EBNA3C. EBNA3C is a large nuclear transcription factor involved in modulating transcription activated by a cellular repressor RBP-Jkappa and other transcription factors. We are interested in other related functions of EBNA3C through its interactions with a number of other cellular molecules. Screens to identify other cellular targets have identified a number of interesting targets associated with EBNA3C. These molecules are involved in cell division, metastasis, apoptosis, cell cycle regulation and regulation of protein degradation. We are currently pursuing a number of these molecules in an effort to demonstrate their biochemical, structural and functional relevance in human cancers.
8
20f KSHV is the second human oncogenic herpesvirus, associated with Kaposi's sarcoma (KS) and pleural effusion lymphomas (PELs) or body cavity based lymphomas (BCBLs). KSHV also belongs to the human gammaherpesvirus family with collinear homology to EBV. KSHV infects human B-cells and endothelial cells. The mechanism of KSHV mediated oncogenesis is not understood. Our laboratory is involved in the elucidation of the mechanisms by which KSHV persists and establishes persistent infection in the associated human cancers.
8
21 Rotation Projects
43 Positions available. Please contact Dr. Robertson via mail.
8
1e Lab personnel:
24 Jason Knight, MSTP Candidate
2a Subhash Verma, Postdoctoral Fellow
23 Ke Lan, Postdoctoral Fellow
2c Masano Murukami, Postdoctoral Fellow
28 Sumit Borah, Research Specialist
2a Daniel Kuppers, Research Specialist
26 29
27
Description of Research Expertise
2b Research Interests37 Mechanisms of Oncogenesis by Gammaherpesvirus.
8
cd Key words: oncogenesis, viruses and cancer, viral oncology, Tumor Virology, Gene therapy, Kaposi's Sarcoma, Epstein-Barr Virus, Lymphoproliferative disease, Lymphomas, Microbiome and Cancer.
8
26 Description of Research
287 Epstein-Barr virus (EBV) and Kaposi's sarcoma associated herpesvirus (KSHV) are associated with a number of human malignancies. These include Burkitt's lymphoma, nasopharyngeal carcinoma, Hodgkin's lymphoma, breast carcinoma, Kaposi's sarcoma and body cavity based lymphoma. We are investigating the fundamental mechanisms utilized by these gammaherpesviruses to induce cell mediated growth transformation. We are using genetics, genomics and biochemical approaches to establish unknown pathways involved in these cellular events and attempting to develop models that explain how gammaherpesviruses establish transformation in human cells.
8
3f7 EBV infects human B-lymphocytes and is the etiological agent of infectious mononucleosis. In vitro EBV efficiently growth transforms primary B-lymphocytes. Studies have demonstrated that only a subset of the viral latent genes is essential for EBV mediated transformation. One such gene is the EBV nuclear antigen EBNA3C. EBNA3C is a large nuclear transcription factor involved in modulating transcription activated by a cellular repressor RBP-Jkappa and other transcription factors. We are interested in other related functions of EBNA3C through its interactions with a number of other cellular molecules. Screens to identify other cellular targets have identified a number of interesting targets associated with EBNA3C. These molecules are involved in cell division, metastasis, apoptosis, cell cycle regulation and regulation of protein degradation. We are currently pursuing a number of these molecules in an effort to demonstrate their biochemical, structural and functional relevance in human cancers.
8
20f KSHV is the second human oncogenic herpesvirus, associated with Kaposi's sarcoma (KS) and pleural effusion lymphomas (PELs) or body cavity based lymphomas (BCBLs). KSHV also belongs to the human gammaherpesvirus family with collinear homology to EBV. KSHV infects human B-cells and endothelial cells. The mechanism of KSHV mediated oncogenesis is not understood. Our laboratory is involved in the elucidation of the mechanisms by which KSHV persists and establishes persistent infection in the associated human cancers.
8
21 Rotation Projects
43 Positions available. Please contact Dr. Robertson via mail.
8
1e Lab personnel:
24 Jason Knight, MSTP Candidate
2a Subhash Verma, Postdoctoral Fellow
23 Ke Lan, Postdoctoral Fellow
2c Masano Murukami, Postdoctoral Fellow
28 Sumit Borah, Research Specialist
2a Daniel Kuppers, Research Specialist
26 29
23
13d Abhik Saha, Hem C. Jha, Santosh K. Upadhyay, and Erle S. Robertson: Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection. Proc Natl Acad Sci U S A. Proc Natl Acad Sci U S A, 112( 37): E5199-207, Sept 2015.
115 Sun Z1, Jha HC1, Robertson ES2.: Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis. J. Virology 89(20), Oct 2015.
107 Jha HC1, Shukla SK1, Lu J1, Aj MP1, Banerjee S1, Robertson ES1.: Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation. Oncotarget Oct 2015.
fe Gandhi J, Gaur N, Khera L, Kaul R, Robertson ES.: COX-2 induces lytic reactivation of EBV through PGE2 by modulating the EP receptor signaling pathway. Virology 484: 1-14, Oct 2015.
106 Dzeng RK1, Jha HC1, Lu J1, Saha A1, Banerjee S1, Robertson ES2.: Small molecule growth inhibitors of human oncogenic gammaherpesvirus infected B-cells. Mol Oncol. 9(2): 365–376, Feb 2015.
de Baldwin DA, Feldman M, Alwine JC, Robertson ES.: Metagenomic assay for identification of microbial pathogens in tumor tissues. MBio 5(5), Sept. 2014.
105 Banerjee S1, Lu J1, Cai Q2, Sun Z1, Jha HC1, Robertson ES1.: EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation. PLoS Pathogens Aug 2014.
13a Sun Z, Xiao B, Jha HC, Lu J, Banerjee S, Robertson ES.: Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1. J. Virology 88(13), Jul 2014.
13c Lu J1, Jha HC, Verma SC, Sun Z, Banerjee S, Dzeng R, Robertson ES.: Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin. J. Virology 88(8): 4204-4217, Apr 2014.
2c
7
1d
1f
Selected Publications
114 Banerjee S, Wei Z, Tan F, Peck KN, Shih N, Feldman M, Rebbeck TR, Alwine JC, Robertson ES.: Distinct microbiological signatures associated with triple negative breast cancer. Scientific Reports Oct 2015.13d Abhik Saha, Hem C. Jha, Santosh K. Upadhyay, and Erle S. Robertson: Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection. Proc Natl Acad Sci U S A. Proc Natl Acad Sci U S A, 112( 37): E5199-207, Sept 2015.
115 Sun Z1, Jha HC1, Robertson ES2.: Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis. J. Virology 89(20), Oct 2015.
107 Jha HC1, Shukla SK1, Lu J1, Aj MP1, Banerjee S1, Robertson ES1.: Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation. Oncotarget Oct 2015.
fe Gandhi J, Gaur N, Khera L, Kaul R, Robertson ES.: COX-2 induces lytic reactivation of EBV through PGE2 by modulating the EP receptor signaling pathway. Virology 484: 1-14, Oct 2015.
106 Dzeng RK1, Jha HC1, Lu J1, Saha A1, Banerjee S1, Robertson ES2.: Small molecule growth inhibitors of human oncogenic gammaherpesvirus infected B-cells. Mol Oncol. 9(2): 365–376, Feb 2015.
de Baldwin DA, Feldman M, Alwine JC, Robertson ES.: Metagenomic assay for identification of microbial pathogens in tumor tissues. MBio 5(5), Sept. 2014.
105 Banerjee S1, Lu J1, Cai Q2, Sun Z1, Jha HC1, Robertson ES1.: EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation. PLoS Pathogens Aug 2014.
13a Sun Z, Xiao B, Jha HC, Lu J, Banerjee S, Robertson ES.: Kaposi's sarcoma-associated herpesvirus-encoded LANA can induce chromosomal instability through targeted degradation of the mitotic checkpoint kinase Bub1. J. Virology 88(13), Jul 2014.
13c Lu J1, Jha HC, Verma SC, Sun Z, Banerjee S, Dzeng R, Robertson ES.: Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin. J. Virology 88(8): 4204-4217, Apr 2014.
2c